Covance, CORL collaborate for ocular drug development

Covance and Comparative Ophthalmic Research Laboratories (CORL) announce their collaboration as a resource for ocular drug development.

Covance and Comparative Ophthalmic Research Laboratories (CORL) announce their collaboration as a resource for ocular drug development.

Covance provides testing services for the pharmaceutical and biotechnology industries. CORL is a collaborative team of internationally recognized vision scientists providing world-class vision research support for industry.

Having worked together for the past 10 years, the Covance/CORL alliance brings an unprecedented breadth of expertise and depth of knowledge to ocular drug development, the organizations said in a prepared joint statement.

Through the collaboration, the organizations are able to provide advanced ophthalmic techniques and complex study designs, Good Laboratory Practice-compliant studies, and close proximity for maximum study responsiveness.

For more information, visit Covance at Booth 614.